Signed a shareholder agreement with Neurophet (South Korea) to establish a joint venture.

Joined hands with French strategic partner Dosisoft to attend the 18th National Congress of Nuclear Medicine & 2025 Annual Academic Conference of the Chinese Medical Association;
Co‑hosted a training course on the application of internal radiation dose assessment systems with Dosisoft.

Participated in the 3rd Academic Conference on Nuclear Medicine and Molecular Imaging & Annual Conference of the Medical Physics Branch of the Chinese Nuclear Society, and gave a keynote sharing on AI‑assisted Diagnostic Support for Large‑scale Nuclear Medicine Examinations and the Establishment of Corresponding Billing Items.

CEO Zeng Hui attended the 12th Annual Conference of Nuclear Medicine Physicians of the Chinese Medical Doctor Association, delivered a keynote speech, and demonstrated company products.

Established a joint venture with mediCAD® (Germany), further advancing internationalization.

Participated in the 15th Asian Nuclear Medicine Congress and the 7th China‑Japan‑Korea Nuclear Medicine Annual Conference in Shenyang.

Participated in the 17th Chinese Cardiovascular Nuclear Medicine Annual Conference in Harbin.

Participated in the Chinese Nuclear Medicine Conference in Xi’an.

Held the 1st Lado Nuclear Medicine New Technology Application Training Course at Lado Teleconsultation Center.

Participated in the 18th Chinese Cardiovascular Nuclear Medicine Annual Conference & 2017 Annual Meeting of the Chinese Medical Association Nuclear Medicine Branch – Brain Function Imaging Session in Zunyi;
Participated in the Conclusion Meeting of the Chinese Normal Database for SPECT‑MPI and Nuclear Cardiology Symposium in Shenyang.

Participated in the Nuclear Medicine Session of the 4th Wuhan International Cardiovascular Disease Conference.

Participated in the 15th Asian Nuclear Medicine Congress and the 7th China‑Japan‑Korea Nuclear Medicine Annual Conference in Shenyang.

Participated in the 17th Chinese Cardiovascular Nuclear Medicine Annual Conference in Harbin.

Participated in the Chinese Nuclear Medicine Conference hosted by the Nuclear Medicine Branch of the Chinese Medical Association in Xi’an.

Held the 1st Lado Nuclear Medicine New Technology Application Training Course at Lado Teleconsultation Center.

Lado DWS III System officially put into use at the First Hospital of China Medical University.

Participated in the 2nd International Molecular Imaging Summit Forum in Xiamen, hosted by the Molecular Imaging Committee of the Biophysics Society of China.

Co‑organized the 1st Lado Cup Annual Excellent Image Selection with Chinese Journal of Nuclear Medicine; became the only professional software manufacturer from China to exhibit at the 8th Asia‑Oceania Congress of Nuclear Medicine.

Took the lead in launching a more comprehensive, safer, and more reliable local area network system designed exclusively for PET/PET‑CT centers.

Established Guangzhou R&D Center.

Launched data interface protocols with multiple PACS vendors; Lado Reporting System successfully connected with Junhui No.2 (PACS system of the Medical Department of the General Logistics Department).

Participated in the annual National Nuclear Medicine Conference in Guangzhou and launched the Medical Intelligent Nuclear Medicine Network System, becoming an industry leader.

Successfully connected multiple SPECT/ECT/PET systems at Guangdong Provincial People’s Hospital, realizing real local area network design and construction for internal nuclear medicine.

Nuclear Medicine Department, Tongji Hospital Affiliated to Tongji Medical University became the first official customer of Lado Intelligent Reporting System.

First version of the Medical Intelligent Reporting System launched.

Company founded.